Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis.
Rev Inst Med Trop Sao Paulo
; 64: e61, 2022.
Article
in En
| MEDLINE
| ID: mdl-36197422
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis C
/
Hepatitis C, Chronic
Type of study:
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Rev Inst Med Trop Sao Paulo
Year:
2022
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Brazil